The mortality rates from skin and subcutaneous tissue diseases vary significantly across countries. In 2023, Brazil had the highest mortality rate at 7.94 per 1,000 deaths, followed by the United States at 5.87. Poland and Portugal exhibited substantial increases from the prior year, with growth rates of 14.27% and 16.25%, respectively, while Slovenia saw a notable decrease at -11.42%. In contrast, countries such as Japan, Argentina, and Colombia also recorded significant increments in mortality rates. Several Western European countries, including Germany, the UK, and Spain, remained comparatively stable throughout this period.
Future trends to watch include potential implications of healthcare advancements and public health initiatives aiming to reduce these mortality rates, especially in high-incidence countries. Also, emerging treatment technologies and awareness campaigns in countries with rising rates might play crucial roles in altering these trends. Monitoring changes in climate and environmental factors could also impact the mortality landscape for skin diseases globally.
Top countries in Skin and Subcutaneous Tissue Diseases Mortality by Country
| # | 10 Countries | Units (Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Brazil | 7,940 | 2023 | +4.05% | +4.83% | View data |
| 2 | 2 United States | 5,870 | 2023 | +1.03% | +2.42% | View data |
| 3 | 3 Mexico | 4,990 | 2023 | +12.29% | +5.56% | View data |
| 4 | 4 Argentina | 3,190 | 2023 | +6.37% | +3.37% | View data |
| 5 | 5 Japan | 3,190 | 2023 | +3.88% | +3.7% | View data |
| 6 | 6 United Kingdom | 2,310 | 2023 | +1.23% | +0.31% | View data |
| 7 | 7 Spain | 2,120 | 2023 | +2.47% | +3% | View data |
| 8 | 8 Germany | 1,850 | 2023 | +1.99% | +2.95% | View data |
| 9 | 9 Colombia | 1,460 | 2023 | +1.24% | +5.18% | View data |
| 10 | 10 Peru | 972 | 2023 | +11.85% | +4.63% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...